Edition:
United Kingdom

Consun Pharmaceutical Group Ltd (1681.HK)

1681.HK on Hong Kong Stock

4.62HKD
3:12am BST
Change (% chg)

HK$0.01 (+0.22%)
Prev Close
HK$4.61
Open
HK$4.61
Day's High
HK$4.62
Day's Low
HK$4.59
Volume
42,000
Avg. Vol
1,216,574
52-wk High
HK$6.73
52-wk Low
HK$4.05

Latest Key Developments (Source: Significant Developments)

Consun Pharmaceutical Group Says HY Revenue Rmb941 Mln, Up 8.3%
Wednesday, 21 Aug 2019 

Aug 21 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>::HY REVENUE RMB941,036,000, UP 8.3%.HY PROFIT ATTRIBUTABLE RMB 249.5 MILLION ,UP 13.9%.BOARD HAS DECLARED AN INTERIM DIVIDEND OF HKD0.1 PER SHARE.  Full Article

Consun Pharmaceutical Updates On Deal For Cooperative Development Of Site At Yulin City
Friday, 31 May 2019 

May 31 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>::UPDATES ON DEAL IN RELATION TO COOPERATIVE DEVELOPMENT OF SITE LOCATED AT YULIN CITY, GUANGXI PROVINCE.PARTIES ENTER SUPPLEMENTAL AGREEMENT THAT SETS TERMS FOR INTENDED DISPOSALS OF YULIN YUNXIANG BY YULIN PHARMACEUTICAL.DISPOSAL BY YULIN PHARMACEUTICAL TO GUANGXI HUAFA AND YULIN SHUNLANG AT AGGREGATE INVESTMENT RETURN AFTER TAX OF RMB700 MILLION.  Full Article

Consun Pharmaceutical Group Posts FY Profit Attributable Of RMB465.4 Mln
Wednesday, 20 Mar 2019 

March 20 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>::PROPOSED TO DECLARE A FINAL DIVIDEND OF HKD0.20 PER SHARE FOR YEAR ENDED 31 DECEMBER 2018.FY REVENUE AMOUNTED TO RMB1.84 BILLION, UP ABOUT 11.1%.FY PROFIT ATTRIBUTABLE RMB465.4 MILLION VERSUS RMB396.2 MILLION.  Full Article

Consun Pharmaceutical Group Posts H1 Profit Attributable Of RMB219 MLN
Tuesday, 21 Aug 2018 

Aug 21 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>::HY REVENUE RMB869 MILLION, UP ABOUT 13 PERCENT.H1 PROFIT ATTRIBUTABLE RMB219 MLN UP 18.5%.  Full Article

Consun Pharmaceutical Group Appoints Li Qian As Vice Chairlady
Thursday, 31 May 2018 

May 31 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>::LI QIAN APPOINTED AS VICE CHAIRLADY OF BOARD.TANG NING APPOINTED AS AN EXECUTIVE DIRECTOR.  Full Article

Far East Horizon's unit subscribes for 43.6 mln placing shares of Consun Pharmaceutical Group
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Far East Horizon Ltd <3360.HK>::Unit subscribes for 43.6 million placing shares of Consun Pharmaceutical Group at HK$6.60 per placing share​.  Full Article

Consun Pharmaceutical considering spin-off and listing of Guangxi Yulin Pharmaceutical Group
Wednesday, 18 Oct 2017 

Oct 19 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>:Board considering spin-off and listing of Guangxi Yulin Pharmaceutical Group and its subsidiaries​.  Full Article